A Phase 1 trial with CAT-5571 for the potential treatment of cystic fibrosis (CF).
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2016
At a glance
- Drugs CAT 5571 (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 02 Dec 2016 New trial record
- 17 Nov 2016 According to Catabasis Pharmaceuticals media release, company plans to initiate this trial in Q4 2017 or Q1 2018.